Effects of Antimuscarinic Drugs on Both Urinary Frequency and Cognitive Impairment in Conscious, Nonrestrained Rats
スポンサーリンク
概要
- 論文の詳細を見る
Recent studies indicate a risk of learning and memory impairments when patients with senile dementia are treated with antimuscarinic drugs. In this study, we compared the effectiveness of propiverine hydrochloride (propiverine) and oxybutynin chloride (oxybutynin) on the increased urinary frequency and cognitive impairment induced by nucleus basalis magnocellularis (nBM) lesioning in conscious and nonrestrained rats. For examination of bladder function, nBM-lesioned rats were given total parenteral nutrition regimens for 8 days. Propiverine administered orally at 0.3, 3 and 30 mg/kg on the postoperative day 7 significantly lessened the increase in the frequency of voiding caused by the nBM lesion, whereas oxybutynin administration did not show any improvement at 0.1 or 1 mg/kg but did so at 10 mg/kg. To examine the memory impairment, we trained nBM-lesioned rats in an 8-arm radial maze task for 20 days and then evaluated the effectiveness of oral drug administration on 19th and 20th radial maze performance. The higher rate of errors caused by nBM lesioning was significantly aggravated by oxybutynin at 30 and 100 mg/kg. Propiverine showed slight aggravation of errors, but with no statistical significance at any dose, 30, 100 or 300 mg/kg. These results suggest that propiverine has comparatively less effect on the cognitive impairment than oxybutynin.
- 社団法人 日本薬理学会の論文
- 2001-09-01
著者
-
Matsuura Naosuke
Pharmacology Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Oka Toshinori
Pharmacology Research Laboratory R&d Headquarters Tokushima Research Center Taiho Pharmaceutical
-
Oka Toshinori
Pharmacology Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
KIRIMOTO Tsukasa
Pharmacology Research Laboratory, Taiho Pharmaceutical Co., Ltd.,
-
NAKANO Koushi
Pharmacology Research Laboratory, Taiho Pharmaceutical Co., Ltd.
-
Matsuura Naosuke
Pharmacobioregulation Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Nakano Koushi
Pharmacology Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Kirimoto Tsukasa
Pharmacology Research Laboratory Taiho Pharmaceutical Co. Ltd.
関連論文
- Effects of MET-88,a γ-Butyrobetaine Hydroxylase Inhibitor, on Tissue Carnitine and Lipid Levels in Rats
- Hyperlipemia and Early Pancreatic Injury Induced by Ethanol Intake in Rats
- Effects of Antimuscarinic Drugs on Both Urinary Frequency and Cognitive Impairment in Conscious, Nonrestrained Rats
- Protein Kinase C Activation by Helicobacter pylori in Human Gastric Epithelial Cells Limits Interleukin-8 Production Through Suppression of Extracellular Signal-Regulated Kinase
- TAS-301 Blocks Receptor-Operated Calcium Influx and Inhibits Rat Vascular Smooth Muscle Cell Proliferation Induced by Basic Fibroblast Growth Factor and Platelet-Derived Growth Factor